Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Q2 FY27 Results: Net Profit ₹263.8 Cr, Down 56.8% YoY

Glenmark Pharmaceuticals Ltd reported revenue from operations of ₹4,247 Cr (-29.8% YoY) and net profit of ₹263.8 Cr (-56.8% YoY) for Q2 FY27.

Key figure

Net profit ₹263.8 Cr · -56.8% YoY

Glenmark Pharmaceuticals Q1 FY27 Results: Net Profit ₹482.8 Cr, Up 927.2% YoY

Glenmark Pharmaceuticals Ltd reported revenue from operations of ₹4,018 Cr (+23.1% YoY) and net profit of ₹482.8 Cr (+927.2% YoY) for Q1 FY27.

Key figure

Net profit ₹482.8 Cr · +927.2% YoY

Glenmark Pharmaceuticals Q4 FY26 Results: Net Profit ₹301.3 Cr, Up 6747.7% YoY

Glenmark Pharmaceuticals Ltd reported revenue from operations of ₹3,771 Cr (+15.8% YoY) and net profit of ₹301.3 Cr (+6747.7% YoY) for Q4 FY26.

Key figure

Net profit ₹301.3 Cr · +6747.7% YoY

Glenmark Pharmaceuticals Financial Results

Glenmark Pharmaceuticals approved FY26 audited financial results and recommended a 250% dividend. The Board's approval highlights the company's annual performance and shareholder reward plans.

Glenmark Pharmaceuticals Q3 FY26 Results: Net Profit ₹403 Cr, Up 15.8% YoY

Glenmark Pharmaceuticals Ltd reported net profit of ₹403 Cr (+15.8% YoY) for Q3 FY26.

Key figure

Net profit ₹403 Cr · +15.8% YoY